5 Key Takeaways

• 1

  Cirena has launched high-quality long RNA to support CRISPR and genome-editing research globally.

• 2

  The company addresses delays in obtaining long RNA, which historically required complex assembly and purification.

• 3

  Cirena's technology enables rapid production of long RNA, enhancing editing efficiency and precision.

• 4

  Researchers are increasingly using longer guide RNAs to improve CRISPR applications and reduce off-target effects.

• 5

  Cirena's reliable delivery supports various research fields, including oncology, vaccine development, and gene regulation.